Found: 9
Select item for more details and to access through your institution.
Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 9952, doi. 10.3390/ijms23179952
- By:
- Publication type:
- Article
miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Interleukin-8 and Interleukin-6 Are Biomarkers of Poor Prognosis in Esophageal Squamous Cell Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 1997, doi. 10.3390/cancers15071997
- By:
- Publication type:
- Article
Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5477, doi. 10.3390/cancers13215477
- By:
- Publication type:
- Article
A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 3, p. 668, doi. 10.3390/cells10030668
- By:
- Publication type:
- Article
Identification and performance evaluation of housekeeping genes for microRNA expression normalization by reverse transcription-quantitative PCR using liquid-based cervical cytology samples.
- Published in:
- Oncology Letters, 2019, v. 18, n. 5, p. 4753, doi. 10.3892/ol.2019.10824
- By:
- Publication type:
- Article
The digital expression profile of BMP7, CDKN2C, HIST1H3G, and PKMYT1 genes improves high‐grade cervical lesion detection in liquid‐based cytology.
- Published in:
- Cancer Cytopathology, 2023, v. 131, n. 7, p. 454, doi. 10.1002/cncy.22704
- By:
- Publication type:
- Article
Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48657-6
- By:
- Publication type:
- Article
MicroRNA‑130a‑3p inhibition suppresses cervical cancer cell progression.
- Published in:
- Oncology Reports, 2023, v. 49, n. 5, p. N.PAG, doi. 10.3892/or.2023.8546
- By:
- Publication type:
- Article